Organigram Global Inc.
General ticker "OGI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $194.4M (TTM average)
Organigram Global Inc. does not follow the US Stock Market performance with the rate: -27.9%.
Estimated limits based on current volatility of 1.7%: low 0.91$, high 0.94$
Factors to consider:
- Total employees count: 2 (0.0%) as of 2025
- Current price 39.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [1.41$, 2.38$]
- 2026-09-30 to 2027-09-30 estimated range: [1.53$, 2.54$]
Financial Metrics affecting the OGI estimates:
- Positive: with PPE of -12.5 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.12
- Positive: -40.59 < Investing cash flow per share per price, % of -25.04
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -3.27
- Positive: 58.56 < Shareholder equity ratio, % of 62.10 <= 69.38
- Positive: -51.61 < Industry operating profit margin (median), % of -19.48
Short-term OGI quotes
Long-term OGI plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | CA$149.21MM | CA$159.84MM | CA$186.09MM |
| Operating Expenses | CA$391.94MM | CA$194.60MM | CA$249.50MM |
| Operating Income | CA$-242.74MM | CA$-34.76MM | CA$-63.41MM |
| Non-Operating Income | CA$9.74MM | CA$-10.68MM | CA$35.74MM |
| R&D Expense | CA$12.19MM | CA$11.20MM | CA$10.95MM |
| Income(Loss) | CA$-233.00MM | CA$-45.44MM | CA$-27.66MM |
| Taxes | CA$-3.52MM | CA$0.00MM | CA$-9.89MM |
| Net Income(Loss)* | CA$-229.48MM | CA$-45.44MM | CA$-10.79MM |
| Stockholders Equity | CA$271.62MM | CA$305.99MM | CA$349.13MM |
| Assets | CA$298.45MM | CA$407.86MM | CA$562.21MM |
| Operating Cash Flow | CA$-35.08MM | CA$3.87MM | CA$-7.59MM |
| Capital expenditure | CA$26.90MM | CA$5.34MM | CA$17.05MM |
| Investing Cash Flow | CA$1.35MM | CA$-30.80MM | CA$-81.07MM |
| Financing Cash Flow | CA$-0.81MM | CA$107.78MM | CA$39.33MM |
| Earnings Per Share** | CA$-2.82 | CA$-0.48 | CA$-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.